These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36898942)

  • 21. Fractional flow reserve guided percutaneous coronary intervention results in reduced ischemic myocardium and improved outcomes.
    Sawant AC; Bhardwaj A; Banerjee K; Jobanputra Y; Kumar A; Parikh P; Kandregula KC; Poddar K; Ellis SG; Nair R; Corbelli J; Kapadia S
    Catheter Cardiovasc Interv; 2018 Oct; 92(4):692-700. PubMed ID: 29405553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Elective Percutaneous Coronary Intervention on Global Absolute Coronary Flow and Flow Reserve Evaluated by Phase-Contrast Cine-Magnetic Resonance Imaging in Relation to Regional Invasive Physiological Indices.
    Kanaji Y; Yonetsu T; Hamaya R; Murai T; Usui E; Hoshino M; Yamaguchi M; Hada M; Kanno Y; Fukuda T; Ohya H; Sumino Y; Sugano A; Lee T; Hirao K; Kakuta T
    Circ Cardiovasc Interv; 2018 Jul; 11(7):e006676. PubMed ID: 30006332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-invasive procedural planning using computed tomography-derived fractional flow reserve.
    Bom MJ; Schumacher SP; Driessen RS; van Diemen PA; Everaars H; de Winter RW; van de Ven PM; van Rossum AC; Sprengers RW; Verouden NJW; Nap A; Opolski MP; Leipsic JA; Danad I; Taylor CA; Knaapen P
    Catheter Cardiovasc Interv; 2021 Mar; 97(4):614-622. PubMed ID: 32845067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Trans-Stent FFR Gradient: What Is its Role in Contemporary PCI?
    Mavromatis K; Sandesara PB
    JACC Cardiovasc Interv; 2022 Nov; 15(21):2203-2205. PubMed ID: 36357024
    [No Abstract]   [Full Text] [Related]  

  • 25. Physiological Distribution and Local Severity of Coronary Artery Disease and Outcomes After Percutaneous Coronary Intervention.
    Shin D; Dai N; Lee SH; Choi KH; Lefieux A; Molony D; Hwang D; Kim HK; Jeon KH; Lee HJ; Jang HJ; Ha SJ; Park TK; Yang JH; Song YB; Hahn JY; Choi SH; Doh JH; Shin ES; Nam CW; Koo BK; Gwon HC; Ge J; Lee JM
    JACC Cardiovasc Interv; 2021 Aug; 14(16):1771-1785. PubMed ID: 34412795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential Impact of Coronary Revascularization on Long-Term Clinical Outcome According to Coronary Flow Characteristics: Analysis of the International ILIAS Registry.
    Hamaya R; van de Hoef TP; Lee JM; Hoshino M; Kanaji Y; Murai T; Boerhout CKM; de Waard GA; Jung JH; Lee SH; Mejia Renteria H; Echavarria-Pinto M; Meuwissen M; Matsuo H; Madera-Cambero M; Eftekhari A; Effat MA; Marques K; Doh JH; Christiansen EH; Banerjee R; Nam CW; Niccoli G; Nakayama M; Tanaka N; Shin ES; Sasano T; Chamuleau SAJ; Knaapen P; Escaned J; Koo BK; Piek JJ; Kakuta T
    Circ Cardiovasc Interv; 2022 Jun; 15(6):e011948. PubMed ID: 35603622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).
    Lønborg J; Engstrøm T; Kelbæk H; Helqvist S; Kløvgaard L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L; Høfsten DE;
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compared Outcomes of ST-Segment-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER-MI Trial.
    Denormandie P; Simon T; Cayla G; Steg PG; Montalescot G; Durand-Zaleski I; le Bras A; le Breton H; Valy Y; Schiele F; Cuisset T; Vanzetto G; Levesque S; Goube P; Nallet O; Angoulvant D; Roubille F; Charles Nelson A; Chatellier G; Danchin N; Puymirat E
    Circ Cardiovasc Interv; 2021 Nov; 14(11):e011314. PubMed ID: 34420366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Impact of Residual Anatomic Disease Burden After Functionally Complete Revascularization.
    Lee JM; Hwang D; Choi KH; Lee HJ; Song YB; Cho YK; Nam CW; Hahn JY; Shin ES; Doh JH; Hoshino M; Hamaya R; Kanaji Y; Murai T; Zhang JJ; Ye F; Li X; Ge Z; Chen SL; Kakuta T; Koo BK
    Circ Cardiovasc Interv; 2020 Sep; 13(9):e009232. PubMed ID: 32895005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: a comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease.
    Zimmermann FM; De Bruyne B; Pijls NH; Desai M; Oldroyd KG; Park SJ; Reardon MJ; Wendler O; Woo J; Yeung AC; Fearon WF
    Am Heart J; 2015 Oct; 170(4):619-626.e2. PubMed ID: 26386784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative flow ratio-guided strategy versus angiography-guided strategy for percutaneous coronary intervention: Rationale and design of the FAVOR III China trial.
    Song L; Tu S; Sun Z; Wang Y; Ding D; Guan C; Xie L; Escaned J; Fearon WF; Kirtane AJ; Serruys PW; Wijns W; Windecker S; Leon MB; Stone GW; Qiao S; Xu B;
    Am Heart J; 2020 May; 223():72-80. PubMed ID: 32179258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential Prognostic Value of Revascularization for Coronary Stenosis With Intermediate FFR by Coronary Flow Reserve.
    Kim J; Shin D; Lee JM; Lee SH; Hong D; Choi KH; Hwang D; Boerhout CKM; de Waard GA; Jung JH; Mejia-Renteria H; Hoshino M; Echavarria-Pinto M; Meuwissen M; Matsuo H; Madera-Cambero M; Eftekhari A; Effat MA; Murai T; Marques K; Doh JH; Christiansen EH; Banerjee R; Kim HK; Nam CW; Niccoli G; Nakayama M; Tanaka N; Shin ES; Chamuleau SAJ; van Royen N; Knaapen P; Koo BK; Kakuta T; Escaned J; Piek JJ; van de Hoef TP;
    JACC Cardiovasc Interv; 2022 May; 15(10):1033-1043. PubMed ID: 35490124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FFR
    Fearon WF; Parikh RV
    JACC Cardiovasc Imaging; 2022 Jul; 15(7):1256-1258. PubMed ID: 35798402
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparing the adverse clinical outcomes associated with fraction flow reserve-guided versus angiography-guided percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
    Bundhun PK; Yanamala CM; Huang F
    BMC Cardiovasc Disord; 2016 Dec; 16(1):249. PubMed ID: 27912739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal Revascularization Threshold of Fractional Flow Reserve and its Effect on Outcomes: Perspectives From a High-Volume Center in China.
    Du Y; Yang B; Zhang J; Liu W; Wang Z; Ji Q; Ma X; Han H; Guo Y; Liu X; Zhao Y; Zhou Y
    Angiology; 2019 May; 70(5):423-430. PubMed ID: 30343583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virtual Coronary Intervention: A Treatment Planning Tool Based Upon the Angiogram.
    Gosling RC; Morris PD; Silva Soto DA; Lawford PV; Hose DR; Gunn JP
    JACC Cardiovasc Imaging; 2019 May; 12(5):865-872. PubMed ID: 29550308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rationale and design of the precise percutaneous coronary intervention plan (P3) study: Prospective evaluation of a virtual computed tomography-based percutaneous intervention planner.
    Nagumo S; Collet C; Norgaard BL; Otake H; Ko B; Koo BK; Leipsic J; Andreini D; Heggermont W; Jensen JM; Takahashi Y; Ihdayhid A; Zhang Z; Barbato E; Maeng M; Mizukami T; Bartunek J; Updegrove A; Penicka M; Rogers C; Taylor C; De Bruyne B; Sonck J
    Clin Cardiol; 2021 Apr; 44(4):446-454. PubMed ID: 33656754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Implications of Prestent Pullback Pressure Gradient and Poststent Quantitative Flow Ratio in Patients Undergoing Percutaneous Coronary Intervention.
    Dai N; Yuan S; Dou K; Zhang R; Hu N; He J; Guan C; Zou T; Qiao Z; Duan S; Xie L; Yu Y; Zhang Y; Xu B; Ge J
    J Am Heart Assoc; 2022 Jun; 11(11):e024903. PubMed ID: 35656982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Implications of Post-Intervention Resting Pd/Pa and Fractional Flow Reserve in Patients With Stent Implantation.
    Shin D; Lee SH; Lee JM; Choi KH; Hwang D; Lee HJ; Jang HJ; Kim HK; Kwak JJ; Ha SJ; Song YB; Shin ES; Doh JH
    JACC Cardiovasc Interv; 2020 Aug; 13(16):1920-1933. PubMed ID: 32819481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and Prognostic Impact From Objective Analysis of Post-Angioplasty Fractional Flow Reserve Pullback.
    Lee SH; Kim J; Lefieux A; Molony D; Shin D; Hwang D; Choi KH; Chang HS; Jeon KH; Lee HJ; Jang HJ; Kim HK; Ha SJ; Park TK; Yang JH; Song YB; Hahn JY; Choi SH; Doh JH; Shin ES; Nam CW; Koo BK; Gwon HC; Lee JM
    JACC Cardiovasc Interv; 2021 Sep; 14(17):1888-1900. PubMed ID: 34503739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.